Sort by
Refine Your Search
-
Country
-
Employer
- University of North Carolina at Chapel Hill
- Baylor College of Medicine
- Duke University
- Fred Hutchinson Cancer Center
- Stanford University
- University of Gdansk
- University of Washington
- Yale University
- CNRS
- Massachusetts Institute of Technology
- The University of Texas Southwestern Medical Center (UT Southwestern Medical Center)
- University of Florida
- University of Kentucky
- University of Minnesota
- Aarhus University
- CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences
- Human Technopole
- Indiana University
- Institut Pasteur
- Institute of Bioorganic Chemistry Polish Academy of Sciences
- Institute of Macromolecular Chemistry CAS
- Lunds universitet
- Luxembourg Institute of Health
- MAYNOOTH UNIVERSITY
- Massachusetts Institute of Technology (MIT)
- Maynooth University
- Michigan State University
- Nencki Institute of Experimental Biology
- Pennsylvania State University
- Radboud University Medical Center (Radboudumc)
- Research Center for Molecular Medicine (CeMM), ÖAW
- Rutgers University
- SUNY University at Buffalo
- St Jude Children's Research Hospital
- The Wistar Institute
- Umeå University
- University Hospital Magdeburg
- University of California San Diego - Ganesan Lab
- University of California, Los Angeles
- University of Colorado
- University of Kansas Medical Center
- University of Louisville
- University of Maryland, Baltimore
- University of Miami
- University of Pittsburgh, Pittsburgh , Pennsylvania, US
- Utrecht University
- Washington University in St. Louis
- 37 more »
- « less
-
Field
-
focuses on development of novel immunotherapies to treat autoimmune disease, with an emphasis on Multiple Sclerosis. We are particularly interested in developing new AAV vectors to establish immune
-
elicited by candidate HIV vaccines when administered prophylactically, and/or HIV vaccines when administered therapeutically in combination with novel immunotherapies. The Williams lab has state-of-the-art
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 2 months ago
the goal of not only advancing safe and highly efficacious therapies but also with cost profiles that greatly reduce access barriers for many immunotherapies. We broadly welcome applications from top
-
include: Identifying spatial determinants of therapeutic delivery and response in solid tumors, including antibodies, antibody-drug conjugates, immunotherapies, targeted therapies, and engineered cell
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 2 months ago
cancer, a disease that is intrinsically resistant to T-cell directed immunotherapy. This work has the potential to identify novel myeloid-directed therapeutics and enable personalized approaches to treat
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 2 months ago
. Potential projects include acoustically enhanced immunotherapy, targeted therapeutic delivery to the brain, and ultrasound targeted cancer therapies. Candidates will lead projects, conduct research, mentor
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 2 months ago
projects include acoustically enhanced immunotherapy, targeted therapeutic delivery to the brain, and ultrasound targeted cancer therapies. Candidates will lead projects, conduct research, mentor junior team